Bio-Rad Laboratories (BIO) Treasury Shares (2012 - 2026)

Bio-Rad Laboratories (BIO) has reported Treasury Shares for 15 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares rose 7.83% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 7.83% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 30.76% from the prior year.
• Treasury Shares was $1.1 billion for Q2 2026 at Bio-Rad Laboratories, up from $1.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $4.1 million in Q2 2025 and troughed at $279544.0 in Q1 2022.
• A 5-year average of $2.1 million and a median of $2.3 million in 2024 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 147.99% in 2022, down 29.1% in 2022.
• Over 5 years, Treasury Shares stood at $263.6 million in 2022, then jumped by 139.96% to $632.5 million in 2023, then grew by 22.07% to $772.1 million in 2024, then surged by 30.76% to $1.0 billion in 2025, then advanced by 6.8% to $1.1 billion in 2026.
• The last three Treasury Shares figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.